These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 35369354)

  • 61. The Role of Advanced Cardiovascular Imaging Modalities in Cardio-Oncology: From Early Detection to Unravelling Mechanisms of Cardiotoxicity.
    Leo I; Vidula M; Bisaccia G; Procopio MC; Licordari R; Perotto M; La Vecchia G; Miaris N; Bravo PE; Bucciarelli-Ducci C
    J Clin Med; 2023 Jul; 12(15):. PubMed ID: 37568347
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cardiac complications of cancer therapies.
    Mauro AG; Hunter K; Salloum FN
    Adv Cancer Res; 2022; 155():167-214. PubMed ID: 35779874
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The Role of Cardiac MRI in Animal Models of Cardiotoxicity: Hopes and Challenges.
    Park CJ; Branch ME; Vasu S; Meléndez GC
    J Cardiovasc Transl Res; 2020 Jun; 13(3):367-376. PubMed ID: 32248349
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Current status and future perspectives of onco-cardiology: Importance of early detection and intervention for cardiotoxicity, and cardiovascular complication of novel cancer treatment.
    Kubota S; Hara H; Hiroi Y
    Glob Health Med; 2021 Aug; 3(4):214-225. PubMed ID: 34532602
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Modern Management of Anthracycline-Induced Cardiotoxicity in Lymphoma Patients: Low Occurrence of Cardiotoxicity with Comprehensive Assessment and Tailored Substitution by Nonpegylated Liposomal Doxorubicin.
    Olivieri J; Perna GP; Bocci C; Montevecchi C; Olivieri A; Leoni P; Gini G
    Oncologist; 2017 Apr; 22(4):422-431. PubMed ID: 28275118
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cardiotoxicity of Cancer Therapies.
    Mondal P; Jain D; Aronow WS; Frishman WH
    Cardiol Rev; 2019; 27(5):230-235. PubMed ID: 30433897
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Research progress of cardioprotective agents for prevention of anthracycline cardiotoxicity.
    Zhang J; Cui X; Yan Y; Li M; Yang Y; Wang J; Zhang J
    Am J Transl Res; 2016; 8(7):2862-75. PubMed ID: 27508008
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Novel approaches to the prediction, diagnosis and treatment of cardiac late effects in survivors of childhood cancer: a multi-centre observational study.
    Skitch A; Mital S; Mertens L; Liu P; Kantor P; Grosse-Wortmann L; Manlhiot C; Greenberg M; Nathan PC
    BMC Cancer; 2017 Aug; 17(1):519. PubMed ID: 28774277
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology.
    Pudil R; Mueller C; Čelutkienė J; Henriksen PA; Lenihan D; Dent S; Barac A; Stanway S; Moslehi J; Suter TM; Ky B; Štěrba M; Cardinale D; Cohen-Solal A; Tocchetti CG; Farmakis D; Bergler-Klein J; Anker MS; Von Haehling S; Belenkov Y; Iakobishvili Z; Maack C; Ciardiello F; Ruschitzka F; Coats AJS; Seferovic P; Lainscak M; Piepoli MF; Chioncel O; Bax J; Hulot JS; Skouri H; Hägler-Laube ES; Asteggiano R; Fernandez TL; de Boer RA; Lyon AR
    Eur J Heart Fail; 2020 Nov; 22(11):1966-1983. PubMed ID: 33006257
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Clozapine associated cardiotoxicity: Issues, challenges and way forward.
    Kanniah G; Kumar S
    Asian J Psychiatr; 2020 Apr; 50():101950. PubMed ID: 32109805
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Drug-induced cardiac toxicity and adverse drug reactions, a narrative review.
    Destere A; Merino D; Lavrut T; Rocher F; Viard D; Drici MD; Gérard AO
    Therapie; 2024; 79(2):161-172. PubMed ID: 37957054
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Nuclear medicine imaging methods of radiation-induced cardiotoxicity.
    Polomski ES; Antoni ML; Jukema JW; Kroep JR; Dibbets-Schneider P; Sattler MGA; de Geus-Oei LF
    Semin Nucl Med; 2022 Sep; 52(5):597-610. PubMed ID: 35246310
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cardiovascular safety of oncologic agents: a double-edged sword even in the era of targeted therapies - Part 2.
    Manolis AA; Manolis TA; Mikhailidis DP; Manolis AS
    Expert Opin Drug Saf; 2018 Sep; 17(9):893-915. PubMed ID: 30126303
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Early detection of doxorubicin-induced cardiotoxicity in rats by its cardiac metabolic signature assessed with hyperpolarized MRI.
    Timm KN; Perera C; Ball V; Henry JA; Miller JJ; Kerr M; West JA; Sharma E; Broxholme J; Logan A; Savic D; Dodd MS; Griffin JL; Murphy MP; Heather LC; Tyler DJ
    Commun Biol; 2020 Nov; 3(1):692. PubMed ID: 33214680
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Multiparametric Early Detection and Prediction of Cardiotoxicity Using Myocardial Strain, T1 and T2 Mapping, and Biochemical Markers: A Longitudinal Cardiac Resonance Imaging Study During 2 Years of Follow-Up.
    Giusca S; Korosoglou G; Montenbruck M; Geršak B; Schwarz AK; Esch S; Kelle S; Wülfing P; Dent S; Lenihan D; Steen H
    Circ Cardiovasc Imaging; 2021 Jun; 14(6):e012459. PubMed ID: 34126756
    [TBL] [Abstract][Full Text] [Related]  

  • 76. New Insights in Early Detection of Anticancer Drug-Related Cardiotoxicity Using Perfusion and Metabolic Imaging.
    Cadour F; Thuny F; Sourdon J
    Front Cardiovasc Med; 2022; 9():813883. PubMed ID: 35198613
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Serial Cardiac MRI for Quantification of the Dynamics of Anthracycline-Induced Subclinical Myocardial Injury.
    Zheng Y; Liu H; Zhao L; Guan S; Huo H; Li H; Guo J; Peng X; Hao Y; Jin S; Hou Y; Dai X; Liu T; Zhang X
    J Magn Reson Imaging; 2023 Nov; 58(5):1533-1541. PubMed ID: 36912379
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Trastuzumab-induced cardiotoxicity: a review of clinical risk factors, pharmacologic prevention, and cardiotoxicity of other HER2-directed therapies.
    Dempsey N; Rosenthal A; Dabas N; Kropotova Y; Lippman M; Bishopric NH
    Breast Cancer Res Treat; 2021 Jul; 188(1):21-36. PubMed ID: 34115243
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Anthracycline cardiotoxicity: an update on mechanisms, monitoring and prevention.
    Henriksen PA
    Heart; 2018 Jun; 104(12):971-977. PubMed ID: 29217634
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Association between FDG uptake in the right ventricular myocardium and cancer therapy-induced cardiotoxicity.
    Kim J; Cho SG; Kang SR; Yoo SW; Kwon SY; Min JJ; Bom HS; Song HC
    J Nucl Cardiol; 2020 Dec; 27(6):2154-2163. PubMed ID: 30719656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.